| |
| |
|
| Insider
Information: |
Venkataraman Ganesh |
| Relationship: |
COO & CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
495,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,985,210 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
495,145 |
|
|
| Total
Value |
$25,985,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
COO & CSO |
2018-08-21 |
495,145 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
173 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-12-20 |
4 |
OE |
$0.99 |
$7,128 |
D/D |
7,200 |
416,505 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-02-15 |
4 |
AS |
$12.26 |
$10,274 |
D/D |
(838) |
415,667 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
426,667 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-02-20 |
4 |
AS |
$12.62 |
$2,612 |
D/D |
(207) |
426,460 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-02-25 |
4 |
AS |
$12.43 |
$2,585 |
D/D |
(208) |
426,252 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-02-26 |
4 |
AS |
$12.58 |
$2,302 |
D/D |
(183) |
426,069 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-05-15 |
4 |
AS |
$13.33 |
$2,893 |
D/D |
(217) |
425,852 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-05-21 |
4 |
AS |
$12.83 |
$2,784 |
D/D |
(217) |
425,635 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-05-23 |
4 |
AS |
$13.03 |
$2,788 |
D/D |
(214) |
425,421 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-08-15 |
4 |
AS |
$15.43 |
$3,364 |
D/D |
(218) |
425,203 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-08-20 |
4 |
AS |
$14.47 |
$3,140 |
D/D |
(217) |
424,986 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-08-23 |
4 |
AS |
$14.90 |
$3,159 |
D/D |
(212) |
424,774 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-11-15 |
4 |
AS |
$16.88 |
$3,663 |
D/D |
(217) |
424,557 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-11-19 |
4 |
AS |
$17.17 |
$3,726 |
D/D |
(217) |
424,340 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-11-25 |
4 |
AS |
$17.77 |
$598,409 |
D/D |
(33,211) |
391,129 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-11 |
4 |
AS |
$17.95 |
$1,795 |
D/D |
(100) |
379,029 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-12 |
4 |
AS |
$17.96 |
$590,884 |
D/D |
(32,900) |
346,129 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
19,312 |
365,224 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-18 |
4 |
AS |
$17.96 |
$3,897 |
D/D |
(217) |
345,912 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-19 |
4 |
AS |
$17.86 |
$3,876 |
D/D |
(217) |
365,007 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-21 |
4 |
AS |
$17.70 |
$16,001 |
D/D |
(904) |
364,103 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-25 |
4 |
AS |
$17.47 |
$3,686 |
D/D |
(211) |
363,892 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-03-21 |
4 |
OE |
$4.91 |
$153,192 |
D/D |
31,200 |
395,092 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-05-15 |
4 |
AS |
$11.09 |
$2,407 |
D/D |
(217) |
394,875 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-05-20 |
4 |
AS |
$12.08 |
$2,742 |
D/D |
(227) |
394,648 |
0 |
- |
|
173 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
